Funded Health Care Startups in Dallas
The largest disclosed round in this Dallas health care set is MicroTransponder’s $65M Series F on 2025-03-12; it sits far above the next-highest disclosed…
The largest disclosed round in this Dallas health care set is MicroTransponder’s $65M Series F on 2025-03-12; it sits far above the next-highest disclosed amount of $10M (Care Continuity on 2023-10-20) and above the broader cluster of sub-$10M rounds (e.g., $8M Bloom Health Partners on 2022-11-15; $3M Independence Dental Services on 2023-02-16). A second outlier pattern shows up in disclosure itself: 4 of 14 entries are labeled “undisclosed,” including MobileOp4 (2025-06-03) and Unifeye Vision Partners (2025-05-07), which creates a discontinuity in observable deal sizing.
Dates span from 2020-10-20 (MediBookr) through 2025-06-03 (MobileOp4), with most of the listed rounds concentrating in 2021–2023 (e.g., River Health $2M on 2021-08-12; RealTime Clinic $1M grant on 2021-08-01; multiple entries in 2023-06-20 including HHM Health and The Family Place, both undisclosed). Stage mix skews toward “Series Unknown,” which appears on 8 of 14 rows (e.g., Berkshire Biomedical on 2025-06-02; Medcognetics on 2023-01-26).
Most recent rounds
14 shownRelated listings
Frequently asked
What’s the largest disclosed deal in Dallas health care here, and how does it compare to the rest of the disclosed rounds?
MicroTransponder’s $65M (Series F) on 2025-03-12 is the clear outlier; the next-largest disclosed amount is $10M for Care Continuity on 2023-10-20, with most other disclosed rounds landing at $8M or below (e.g., Bloom Health Partners $8M on 2022-11-15; Independence Dental Services $3M on 2023-02-16).
How much of the list is concentrated in the most recent ~12 months versus older rounds?
Within roughly the last year of the rows shown (2024-05-01 to 2025-06-03), there are 3 entries: MobileOp4 (2025-06-03, undisclosed), Berkshire Biomedical (2025-06-02, $330K), and Unifeye Vision Partners (2025-05-07, undisclosed). The remaining rows are concentrated in earlier windows, including multiple 2023 entries such as Care Continuity (2023-10-20, $10M) and two undisclosed rounds dated 2023-06-20 (The Family Place and HHM Health).
Are there any stage or disclosure patterns that dominate the dataset?
“Series Unknown” appears on 8 of 14 rows, including Berkshire Biomedical (2025-06-02), Care Continuity (2023-10-20), and Medcognetics (2023-01-26). Separately, 4 of 14 entries are “undisclosed” by amount (MobileOp4 on 2025-06-03; Unifeye Vision Partners on 2025-05-07; The Family Place on 2023-06-20; HHM Health on 2023-06-20), which limits how many rounds can be compared by disclosed size.
Which stage mix dominates beyond Series Unknown, and where do the earliest dated rounds land?
Outside “Series Unknown,” Seed is the main named category with 3 rows: Bloom Health Partners ($8M) on 2022-11-15, River Health ($2M) on 2021-08-12, and Physician 360 (2022-09-06, undisclosed). The earliest dated entry shown is MediBookr on 2020-10-20, where the row has no Series label, alongside a later named grant/Seed spread in 2021 (RealTime Clinic grant on 2021-08-01 for $1M).
Are there any notable small-round clusters or low-end anchors you’d watch for in outreach?
The lowest disclosed amount in the dataset is $1M for RealTime Clinic’s grant on 2021-08-01. Several other smaller disclosures cluster in the $2M–$3M range—River Health at $2M on 2021-08-12 and Independence Dental Services at $3M on 2023-02-16—while the mid-to-high disclosed end is concentrated around $8M–$10M (Bloom Health Partners $8M on 2022-11-15; Care Continuity $10M on 2023-10-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.